Novo Nordisk is seeking Chinese approval for its oral weight loss pill
- Novo Nordisk: 17 events in the last 90 days
- Previous: earlier the same day · Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
What happened
China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market
Summary assembled by rule from the sources below